Resultado de búsqueda
15 de may. de 2024 · 22nd Century Group, Inc. is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing, and modern plant breeding.
Hace 2 días · Stock analysis for 22nd Century Group Inc (XXII:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
24 de may. de 2024 · A high-level overview of 22nd Century Group, Inc. (XXII) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
15 de may. de 2024 · 22nd Century Group Reports First Quarter 2024 Financial Results. New Contracts to Boost Second Quarter Revenue. Reduced Operating Costs, Improved Cash Position. Reduced ~$8.0 Million of Outstanding Debt and Liabilities for Equity Exchanges in Q2 2024.
31 de may. de 2024 · 22nd Century Group Investor Relations. contact us by phone 214-597-8200 contact us by email mkreps@xxiicentury.com
28 de may. de 2024 · See the latest 22nd Century Group Inc stock price (XXII:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
Hace 3 días · 22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands.
